Brief: Cue Health Makes De Novo Submission To FDA For Full Clearance Of Its Molecular Covid-19 Test
02/05/2022 14:14
May 2 (Reuters) - Cue Health Inc HLTH.O :
* CUE HEALTH MAKES DE NOVO SUBMISSION TO FDA FOR FULL
CLEARANCE OF
ITS MOLECULAR COVID-19 TEST
Source text for Eikon: ID:nPn4ZfF0Ra
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022